These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3121395)

  • 1. The effect of periovarian adhesions on follicular development in patients undergoing ovarian stimulation for in vitro fertilization-embryo transfer.
    Diamond MP; Pellicer A; Boyers SP; DeCherney AH
    Fertil Steril; 1988 Jan; 49(1):100-3. PubMed ID: 3121395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ovarian adhesive disease upon follicular development in cycles of controlled stimulation for in vitro fertilization.
    Mahadevan MM; Wiseman D; Leader A; Taylor PJ
    Fertil Steril; 1985 Oct; 44(4):489-92. PubMed ID: 2932348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic ovarian status and follicular response to superovulation stimulation in an in vitro fertilization and embryo transfer program].
    Wei Z; Zhang L; Li M
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jan; 32(1):27-30. PubMed ID: 9596867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prorenin response to human chorionic gonadotropin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations.
    Itskovitz J; Sealey JE; Glorioso N; Rosenwaks Z
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7285-9. PubMed ID: 3118364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients with and without gonadotropin surges during follicular recruitment in an in vitro fertilization/embryo transfer program.
    Nader S; Berkowitz AS; Maklad N; Wolf DP; Held B
    Fertil Steril; 1986 Jan; 45(1):75-8. PubMed ID: 3080347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin stimulation for in vitro fertilization and embryo transfer in insulin-dependent diabetics: follicular response, oocyte quality, embryo development, and follicular environment.
    Oehninger S; Hofmann GE; Kreiner D; Acosta AA; Muasher SJ
    Fertil Steril; 1990 Apr; 53(4):741-3. PubMed ID: 2108062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
    Gersak K; Meden-Vrtovec H; Tomazevic T
    Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.
    Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ
    Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of ovarian follicular activity on late proliferative phase serum IGFBP-1 in down-regulated assisted conception cycles.
    Arthur ID; Anthony FW; Masson GM; Thomas EJ
    Hum Reprod; 1994 Aug; 9(8):1417-20. PubMed ID: 7527420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.
    Bernardus RE; Jones GS; Acosta AA; Garcia JE; Liu HC; Jones DL; Rosenwaks Z
    Fertil Steril; 1985 Mar; 43(3):373-8. PubMed ID: 3920087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?
    Samara N; Reis D; Danielli Miller N; Ghetler Y; Berkovitz A; Miller M; Gonen O; Shulman A; Wiser A
    Gynecol Endocrinol; 2015; 31(11):877-9. PubMed ID: 26416777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders.
    Shaker AG; Fleming R; Jamieson ME; Yates RW; Coutts JR
    Fertil Steril; 1992 Nov; 58(5):919-23. PubMed ID: 1426376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstructive pelvic operations for in vitro fertilization.
    Garcia JE; Jones HW; Acosta AA; Andrews MC
    Am J Obstet Gynecol; 1985 Sep; 153(2):172-8. PubMed ID: 2931026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles.
    Kolibianakis EM; Albano C; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5632-7. PubMed ID: 14671145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peri-ovarian adhesions interfere with the diffusion of gonadotrophin into the follicular fluid.
    Nagata Y; Honjou K; Sonoda M; Makino I; Tamura R; Kawarabayashi T
    Hum Reprod; 1998 Aug; 13(8):2072-6. PubMed ID: 9756271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different follicle-stimulating hormone and luteinizing hormone ratios for ovulation induction during in vitro fertilization.
    Tepper R; Tadir Y; Kaplan-Kraicer R; Amit S; Pinkas H; Ovadia J
    Int J Fertil; 1992; 37(6):335-8. PubMed ID: 1360452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of a midcycle follicle-stimulating hormone boost in addition to human chorionic gonadotropin for timing of follicle aspiration in unstimulated in vitro fertilization cycles.
    Lindheim SR; Sauer MV; Francis MM; Macaso T; Lobo R; Paulson RJ
    Gynecol Obstet Invest; 1997; 43(2):76-8. PubMed ID: 9067710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular and estradiol parameters that improve success with natural cycle in vitro fertilization.
    DiMattina M; Gordon JD; Botes A; Celia G; Payson M; Graves-Herring J
    J Reprod Med; 2014; 59(5-6):267-73. PubMed ID: 24937968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.